Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Abstract Introduction Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a debilitating autoimmune neuropathy that is treated with intravenous immunoglobulin (IVIG). The aim of this retrospective study was to investigate the efficacy and safety of the sucrose-free IVIG Octagam® (Oct...
Main Authors: | Chafké Belmokhtar, Pierre Lozeron, David Adams, Jérôme Franques, Arnaud Lacour, Etienne Godet, Mathieu Bataille, Odile Dubourg, Gilles Angibaud, Emilien Delmont, Françoise Bouhour, Philippe Corcia, Jean Pouget |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-03-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s40120-019-0132-5 |
Similar Items
-
Atypical Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2010-11-01) -
Subacute Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005-06-01) -
Childhood subacute inflammatory demyelinating polyneuropathy
by: Chia-Yu Hsu, et al.
Published: (2011-11-01) -
Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
by: Rajabally YA, et al.
Published: (2020-09-01) -
Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges
by: A. S. Rizvanova, et al.
Published: (2020-03-01)